US Stock MarketDetailed Quotes

ENTA Enanta Pharmaceuticals

Watchlist
  • 17.460
  • +0.930+5.63%
Close Mar 28 16:00 ET
  • 17.460
  • 0.0000.00%
Post 17:12 ET
369.38MMarket Cap-2657P/E (TTM)

About Enanta Pharmaceuticals Company

Enanta Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery and development of small molecule drugs for the treatment of viral infections and liver diseases. It produces clinical candidates which targets respiratory syncytial virus (RSV), hepatitis B virus (HBV), and non-alcoholic steatohepatitis (NASH) diseases. The firm also conducts research in human metapneumovirus (hMPV) and SARS-CoV-2 (COVID-19). The company was founded by Peter O. Kliem Martin Karplus, James Hogle, Gerard Wagner, Peter M. Howley, and Gregory L. Verdine in 1995 and is headquartered in Watertown, MA.

Company Profile

SymbolENTA
Company NameEnanta Pharmaceuticals
Listing Date03/21/2013
Issue Price14.00
CEODr. Jay R. Luly, PhD
MarketNASDAQ
Employees145
Securities TypeOrdinary Shares
Fiscal Year Ends09-30
Address500 Arsenal Street
CityWatertown
ProvinceMassachusetts
CountryUnited States of America
Zip Code02472
Phone1-617-607-0800

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Jay R. Luly, PhD
  • Director, President and Chief Executive Officer
  • 7.86M
  • Dr. Yat Sun Or, PhD
  • Chief Scientific Officer
  • 2.97M
  • Paul J. Mellett
  • Chief Financial Officer, Principal Accounting Officer and Chief Administrative Officer
  • 2.85M
  • Nathaniel S. Gardiner, J.D.
  • Chief Legal Officer and Corporate Secretary
  • 2.86M
  • Dr. Tara Lynn Kieffer, PhD
  • Chief Product Strategy Officer
  • 2.04M
  • Brendan Luu
  • Chief Business Officer
  • 2.58M
  • Dr. Scott T. Rottinghaus, M.D.
  • Chief Medical Officer
  • 4.40M
  • Dr. Bruce L.A. Carter,PhD
  • Non-Executive Chairman of the Board
  • 353.91K
  • Dr. Lesley Russell, M.R.C.P.,MB.Ch.B.
  • Independent Director
  • 321.41K
  • Mark G. Foletta
  • Independent Director
  • 331.41K
  • Kristine Peterson
  • Independent Director
  • 326.41K
  • Terry C. Vance
  • Independent Director
  • 333.91K
  • Yujiro S. Hata
  • Independent Director
  • 318.91K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
%Chg